PBMares Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$294K Buy
11,547
+471
+4% +$11.6K 0.05% 155
2025
Q2
$268K Sell
11,076
-118
-1% -$2.75K 0.05% 157
2025
Q1
$284K Sell
11,194
-1,508
-12% -$39.5K 0.06% 154
2024
Q4
$337K Sell
12,702
-124
-1% -$3.36K 0.07% 136
2024
Q3
$371K Sell
12,826
-646
-5% -$18.8K 0.08% 134
2024
Q2
$377K Sell
13,472
-710
-5% -$19.5K 0.09% 125
2024
Q1
$394K Sell
14,182
-4,653
-25% -$129K 0.1% 122
2023
Q4
$542K Sell
18,835
-4,628
-20% -$140K 0.16% 94
2023
Q3
$778K Sell
23,463
-386
-2% -$13.7K 0.28% 65
2023
Q2
$875K Buy
23,849
+4
+0% +$156 0.31% 60
2023
Q1
$973K Buy
23,845
+4
+0% +$173 0.36% 52
2022
Q4
$1.22M Sell
23,841
-18
-0.1% -$863 0.49% 37
2022
Q3
$1.04M Buy
23,859
+444
+2% +$21.6K 0.46% 44
2022
Q2
$1.23M Buy
23,415
+37
+0.2% +$1.89K 0.53% 35
2022
Q1
$1.21M Buy
23,378
+556
+2% +$28.8K 0.75% 32
2021
Q4
$1.35M Buy
22,822
+1,055
+5% +$52.3K 0.57% 32
2021
Q3
$936K Buy
21,767
+4
+0% +$177 0.45% 50
2021
Q2
$852K Sell
21,763
-812
-4% -$31.6K 0.46% 55
2021
Q1
$818K Sell
22,575
-230
-1% -$8.17K 0.67% 53
2020
Q4
$839K Buy
22,805
+1,449
+7% +$53.1K 0.96% 36
2020
Q3
$744K Buy
21,356
+18
+0.1% +$631 1.09% 33
2020
Q2
$662K Hold
21,338
1% 33
2020
Q1
$661K Buy
21,338
+629
+3% +$21.4K 1.04% 29
2019
Q4
$770K Buy
+20,709
New +$738K 0.92% 34

Other funds holding PFE

PBMares Wealth Management's PFE Position: Q3 2025 in Review

PBMares Wealth Management increased its Pfizer (PFE) stake by 4.3% in Q3 2025, buying an estimated $11.6K and bringing the position to 11,547 shares worth $294K. The position accounts for 0.05% of the portfolio, ranked #155.

PBMares Wealth Management first reported a position in PFE in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.35M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • PBMares Wealth Management held 11,547 shares of Pfizer worth $294K as of Q3 2025.
  • PBMares Wealth Management bought 471 Pfizer shares in Q3 2025, an estimated $11.6K.
  • Pfizer made up 0.05% of PBMares Wealth Management's portfolio in Q3 2025, its #155 holding.
  • PBMares Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 24 quarters since.
  • PBMares Wealth Management's Pfizer position peaked at $1.35M in Q4 2021.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on PBMares Wealth Management's 13F filing for Q3 2025, filed 27 Oct 2025.